key: cord-1005698-r2mldcul
authors: Uversky, Vladimir N.; Elrashdy, Fatma; Aljadawi, Abdullah; Ali, Syed Moasfar; Khan, Rizwan Hasan; Redwan, Elrashdy M.
title: Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
date: 2020-11-20
journal: J Neurosci Res
DOI: 10.1002/jnr.24752
sha: 28a51b65e72eeaabe11ca89abf692be6b335f138
doc_id: 1005698
cord_uid: r2mldcul

Without protective and/or therapeutic agents the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection known as coronavirus disease 2019 is quickly spreading worldwide. It has surprising transmissibility potential, since it could infect all ages, gender, and human sectors. It attacks respiratory, gastrointestinal, urinary, hepatic, and endovascular systems and can reach the peripheral nervous system (PNS) and central nervous system (CNS) through known and unknown mechanisms. The reports on the neurological manifestations and complications of the SARS‐CoV‐2 infection are increasing exponentially. Herein, we enumerate seven candidate routes, which the mature or immature SARS‐CoV‐2 components could use to reach the CNS and PNS, utilizing the within‐body cross talk between organs. The majority of SARS‐CoV‐2–infected patients suffer from some neurological manifestations (e.g., confusion, anosmia, and ageusia). It seems that although the mature virus did not reach the CNS or PNS of the majority of patients, its unassembled components and/or the accompanying immune‐mediated responses may be responsible for the observed neurological symptoms. The viral particles and/or its components have been specifically documented in endothelial cells of lung, kidney, skin, and CNS. This means that the blood–endothelial barrier may be considered as the main route for SARS‐CoV‐2 entry into the nervous system, with the barrier disruption being more logical than barrier permeability, as evidenced by postmortem analyses.

outbreak, most patients infected with SARS-CoV-2 and diagnosed with COVID-19 have only mild symptoms or are entirely asymptomatic. Unfortunately, approximately 20% of infected individuals exhibit far more serious symptoms, with 15% being considered "severe" and requiring oxygen, and the remaining 5% being viewed as "critical" and relying on ventilators. Symptoms of these serious cases include signs similar to pneumonia, septic shock, respiratory failure, and even multi-organ failure. Thus far, an estimated 1%-2% of COVID-19 cases have proven to be fatal Li, Guan, et al., 2020) , though it must be noted that the majority of fatalities associated with the disease happened in individuals suffering from chronic afflictions, including various cardiovascular diseases, chronic obstructive pulmonary disease (COPD), and other comorbidities (Wu & McGoogan, 2020) .

Analyses of deceased SARS-CoV-2 patients have shown that the viral particles reach and are distributed in nervous system tissues (Table 1) . This discovery begs several important questions: from where did SARS-CoV-2 come to the nervous system and how did it access the brain? What are the brain infection manifestations? Is viral infection persistent in the brain? Are COVID-19 deaths dependent or independent on brain infection? The goal of this work is to get some logical answers to some of these questions.

To this end, we conducted a comprehensive analysis of existing literature, using the following search strategy and selection criteria. References for this review were collected through searches of PubMed, SCOPUS, and Web of Science for articles published until 10 July 2020. The search terms used were "coronaviruses, SARS-CoV, SARS-CoV-2, 2019-nCov, MERS-CoV, 229E-CoV", and "COVID-19", combined with "nervous system", "neuroinvasion", "neurological manifestation", and "brain. These are HCoV-OC43 (Bruckova et al., 1970; Zhu et al., 2018) and

HCoV-HKU1 (Woo et al., 2005) (β-CoVs of the A lineage or β1CoVs), and HCoV-229E (Hierholzer, 1976; Kaye et al., 1972) and HCoV-NL63 (Fouchier et al., 2004; van der Hoek et al., 2004) (α-CoVs) . Identified in the late 1960s (HCoV-229E and the HCoV-OC43) (Almeida & Tyrrell, 1967; Bradburne et al., 1967; Hamre & Procknow, 1966; Larson et al., 1980; McIntosh et al., 1967) and in [2004] [2005] (HCoV-NL63 (Esper et al., 2005; Fouchier et al., 2004; van der Hoek et al., 2004) and HCoV-HKU1 (Woo et al., 2005) ), these HCoVs are known to be responsible for 3%-10% cases of the common cold and short-term upper respiratory infections that occur mainly in winter, with a short incubation time (Gerna et al., 2006 (Gerna et al., , 2007 , with about 2% of the human population being healthy carriers of an HCoV (Geller et al., 2012; Zumla et al., 2016) . Although these HCoV strains can also cause more serious diseases of the lower respiratory tract, such as bronchitis, bronchiolitis, and pneumonia, especially in newborns or infants, elderly people, and immunocompromised patients (Geller et al., 2012; Zumla et al., 2016) , their phenotypes are generally mild, and as a result, these four HCoVs received relatively little attention. Consequently, there is abundant research into CoV that stems all the way back to the 1930s, which has resulted in a considerable knowledge base and various tools for further examining these pathogens in humans.

Data from the in vitro experiments on culturing SARS-CoV and SARS-CoV-2 on the cell lines derived from different human and animal organs clearly indicated that there are many similarities as well as differences between these two CoVs. One of the interesting points made in this study was that SARS-CoV-2 (but not SARS-CoV) was able to modestly replicate in the neuronal (U251) cells, which highlighted the potential of this virus to cause neurological manifestations (e.g., confusion, anosmia, and ageusia) in patients with COVID-19 . The same study also showed that the pluripotent stem cell (iPSC)-derived BrainSphere model can be infected with SARS-CoV-2 (SARS-CoV-2/Wuhan-1/2020), which exponentially replicated 10-fold there (Bullen et al., 2020) .

The virus particles were found in the neuronal cell body extending into apparent neurite structures. This neural cell model expressed angiotensin-converting enzyme-2 (ACE2, a SARS-CoV-2 receptor on the surface of the host cells interacting with the viral spike (S) protein) but not the transmembrane serine protease-2 (TMPRSS2, the catalytic enzyme responsible for the S protein priming required for the subsequent CoV cell entry), which suggests the presence of alternative proteolytic tools there (Bullen et al., 2020) . This state-ofthe-art 3D organotypic cell culture model was already successfully Significance There are neurological manifestations and complications of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Therefore, similar to other coronaviruses SARS-CoV-2 is a neurotropic virus.

To answer the question on how SARS-CoV-2 infection can reach the human nervous system, we are discussing here seven candidate routes. Among these seven pathways, the blood-endothelial barrier is the main route for SARS-CoV-2 entry into the nervous system. An important other route is breaching of the BBB, permeability of which can be increased by the cytokine storm leading to neuroinflammation. Blebbing of viral-like particles coming in/out of the endothelial wall which pointing to presumed active pathogen entry-transit (transcellular penetration) across the brain microvascular endothelial cells into the neural niche was recorded. Neural cell bodies exhibited distended cytoplasmic vacuoles containing enveloped viral particle exhibiting electron dense centers with distinct stalk-like peplomeric projections Bulfamante et al. (2020) Autopsy within three hours postmortem Human olfactory nerve, gyrus, and brainstem 98-160 nm Spherical particle with crown-like shape and inner dense core and electron-dense periphery, double nuclear envelope, severe damage in the olfactory nerve, autophagy phenomena appeared in the cytoplasm Xu et al. (2005) Although this study is related to SARS-CoV and not to SARS-CoV-2, it is counted in here, since this work includes an immunostaining analysis.

used in the infection studies with the Zika, Dengue, HIV, and John Cunningham (JV) viruses. The most interesting point of these studies was the fact that the functional blood-brain barrier (BBB) had lost its functionality when microglia (which was not derived from the neural precursor cells but from the mesoderm germ layer) invaded the developing brain from the blood, resulting in cytokine release and neuronal damage in models analyzing the infection with HIV and JC viruses (Bullen et al., 2020) . Therefore, one of the reasons why some, but not all, of the patients showed neurological manifestations could be related to the fact that the BBB normally hinders virus entry, but is impaired in some by inflammatory conditions (Bullen et al., 2020) .

Neurotropism of HCoVs represents an interesting problem. Data on the immune-mediated central nervous system (CNS) pathology associated with viral infection are traditionally derived from the analysis of mice infected with a member of the Coronaviridae family, Murine Hepatitis Virus (MHV) strains, which is a β-coronavirus genetically related to Human CoV-OC4347 (Lane & Hosking, 2010) .

Being a group II coronavirus, MHV represents a natural pathogen of mice that typically infects the liver, gastrointestinal (GI) tract, and CNS, and shows various disease manifestations ranging from gastroenteritis to hepatitis and acute and chronic encephalomyelitis Cheever et al. 1949; Holmes & Lai, 1996; McIntosh, 1996; Perlman et al., 1999) . It is recognized that there are at least three major mechanisms of the formation of immune-mediated lesions in CNS. They include: (a) a systemic inflammatory response syndrome which occurs as a result of an excessive host response to the infection and leads to the dysfunction of various organs, including CNS, (b) a direct viral infection of CNS immune cells, such as astrocytes, microglia, and macrophages, leading to the local production of pro-inflammatory cytokines IL-6, TNF-α, IL-1β, and IL12, as well as some toxic agents or subsequent tissue damage via the recruitment and activation of other immune cells and induction of apoptosis (Li et al., 2004) , and (c) generation of an autoimmune reaction by an adaptive immune response directed against host epitopes or proteins, which are either misrecognized by the pathogen-directed antibodies or expressed by damaged tissues (and previously unrecognized by the adaptive immune system) (Bergmann et al., 2006; Natoli et al., 2020; Perlman & Dandekar, 2005) . There is also a possibility for the eventual demyelination caused by immune-mediated events, either through T cells or by means of other cytokine and chemokine pathways (Wu et al., 2000) . (Puelles et al., 2020; Solomon et al., 2020) .

Although the CoVs are not primarily neurotropic viruses and the most published reports defined the respiratory epithelium as their primary target, there is increasing evidence that neurotropism is indeed a common feature of the viruses Glass et al., 2004; Khan et al., 2020; Li et al., 2012; Wang, Hu, et al., 2020) . In addition to the aforementioned MHV, many other members of the β-CoV family have been documented to show neurotropism. This necessitates gaining a clear understanding of whether SARS-CoV-2 can enter the CNS and cause neuronal injury that may result in acute respiratory distress and potentially some other neurological manifestations.

Human tissue studies displayed an abundance of ACE2 receptors in the epithelia of the small intestine and lung. These receptors were also identified in vesicular systems, such as venous and arterial endothelial cells (ECs) and arterial smooth muscle cells in all organs studied, including the brain (Hamming et al., 2004) . In agreement with these observations, ACE2 immunostaining was widely distributed throughout the brain in the transgenic mouse (K18-hACE2 model) expressing human ACE2 (Doobay et al., 2007) .

A close look at the antigen and viral kinetics of the SARS-CoV virus in transgenic mice revealed that the infection began in the respiratory epithelium, spread rapidly to the alveoli, entered the brain via the olfactory nerve, and progressively invaded cortical and subcortical regions (McCray et al., 2007; Netland et al., 2008) .

It was also shown that, eventually, the infection extended to several vital brainstem nuclei, such as the nucleus tractus solitarii, dorsal motor nucleus of the vagus, and area postrema. Since the dorsal vagal complex (DVC) is located in the medulla oblongata, the lowest region of the brainstem that controls several autonomic activities, including orchestration of the cardiorespiratory function (heart and breathing) and food intake, injuries of this specific region of the brainstem could be detrimental to the maintenance of homeostasis and explain the cardiorespiratory disorder. Although the animals intracranially inoculated with low-dose virus were characterized by a limited viral spreading, they rapidly succumbed to infection (Netland et al., 2008) . In animal models, CoV infection was accompanied by a considerable infiltration of lymphocytes and macrophages in the lungs, resulting in a release of pro-inflammatory cytokines. This occurred in the brain as well as at the pulmonary level, and within 5 days the subject mice entered a lethargic-like state, which would suggest the involvement of the CNS (McCray et al., 2007; Natoli et al., 2020) . These neuroanatomic seem to point to the idea that the infected organisms die as a result of dysfunction of the cardiorespiratory center in the brainstem (Li, Bai, et al., 2020) . In the past, autopsy results of humans with SARS-CoV infections showed strong evidence of the presence of SARS-CoV by immunohistochemistry, realtime reverse transcription PCR, and electron microscopy (Natoli et al., 2020) . Furthermore, individuals with acute SARS-CoV also exhibited the presence of the virus in the cerebrospinal fluid (CSF, Netland et al., 2008) .

Very limited data are currently available on the neurological disorders and pathology in humans with the MERS-CoV infection.

Although the majority of patients infected with MERS-CoV exhibit predominant pulmonary clinical involvement, there are some patients who exhibit neurologic manifestations, such as ataxia, coma, peripheral nerve symptoms, and focal motor deficits (Arabi et al., 2015; Kim et al., 2017; Natoli et al., 2020) . Ex vivo analyses of the MERS-CoV infectivity in various human lung cell lines demonstrated that the virus could infect human neuronal lines (Chan et al., 2013) . In the hDPP4 transgenic mice model, intranasal MERS-CoV inoculation resulted in infection of both lung and brain by the virus at 3-to 9-day and 7-to 9-day postinoculation, respectively,

indicating different viral infection kinetics (Hao et al., 2019) . This may indicate a hematogeneous infection route. The brain is (possibly) infected via the olfactory nerves, and thereafter infection is rapidly spread to some specific brain areas, including the thalamus and brainstem (Netland et al., 2008) . Interestingly, the virus particles were detected only in the brain, but not in the lung, in mice infected with low inoculum doses of MERS-CoV, suggesting that the infection in the CNS played a greater role in the high mortality (Li et al., 2016) . Similar to SARS-CoV, MERS-CoV is also known to replicate in human macrophages and dendritic cells, lending additional support to the hematogeneous hypothesis ).

The infected model brain consequences included a mild perivascular cuffing (Agrawal et al., 2015) , and congestion and dilatation of the cerebral vessels and areas of cellular necrosis in the thalamus, hippocampus, and cerebral cortex (Hao et al., 2019; Natoli et al., 2020) .

Although the SARS-CoV-2 is mainly a respiratory pathogen, it can also manifest neurologically, causing encephalitis and epileptic seizures, which makes CNS involvement likely. The reported neurological sequelae of SARS-CoV-2 further suggest that the neurological impact of the virus needs to be examined. In fact, although the ongoing COVID-19 pandemic is still relatively young, it has already given rise to many neurological and neuroradiological phenotypes, including ageusia, anosmia, Guillain-Barré syndrome, and even acute necrotizing hemorrhagic encephalopathy Poyiadji et al., 2020; Solomon et al., 2020; . Mao et al. recently reported that among the patients with a severe form of COVID-19, more than 88% (78/88) displayed some form of neurologic dysfunction, such as acute cerebrovascular diseases and impaired consciousness . Also, during the current SARS-CoV-2 outbreak, a COVID-19 patient was reported to have lost control over breathing (Li, Bai, et al., 2020) . Since many COVID-19 patients suffer acute respiratory failure, clinicians and health-care professionals must separate them into cases that are either neurologically affected, or do not display any neurological deficits (Baig et al., 2020; Li, Bai, et al., 2020) . It would therefore be beneficial to have a greater understanding of the possible neuroinvasion of the disease, as it can help in the treatment and prevention of respiratory failure related to SARS-CoV-2 (Li, Bai, et al., 2020) .

In a recent report it was demonstrated that both human and mouse olfactory sensory neurons do not express the two key genes involved in SARS-CoV-2 entry, namely TMPRSS243 and ACE2 . However, the olfactory epithelial support cells and stem cells express both of these genes, similar to nasal respiratory epithelium cells . This suggests that the SARS-CoV-2 infection may possess mechanisms that lead to olfactory dysfunction, and also brings into question whether olfactory bulb can serve as an entry point for CoVs. Natoli et al., 2020) . Since the anosmia symptoms appeared in many SARS-CoV-2 infections, these important questions were 

It is accepted now that the SARS-CoV-2 can reach and be manifested in most human organs and tissues ( Figure 1 ). Mao et al. (2020) F I G U R E 1 Respiratory and extra respiratory organ/system COVID-19 prevalence and Solomon et al. (2020) investigated the penetration potential of the virus into the CNS in >220 patients Solomon et al., 2020) . Their results show that 36.4% of the patients had some neurologic abnormalities ranging from some nonspecific manifestations, such as headache, seizure, and dizziness to specific manifestations, such as stroke and loss of sense of taste (ageusia) and smell (anosmia) . In fact, gustatory and olfactory dysfunctions are both prevalent in patients with mild-to-moderate COVID-19, despite not having nasal symptoms, whereas some other neurological symptoms and manifestations can be seen in the more severe COVID-19 cases (Ahmad & Rathore, 2020; Asadi-Pooya & Simani, 2020; Conde Cardona et al., 2020; Lai et al., 2020; Vonck et al., 2020) . It must be noted here that the more severe neurologic symptoms, such as decreased levels of consciousness, or development of seizures and stroke, were more common in patients in the late stages of the infection, and these symptoms were responsible for the heightened mortality rate in severely affected patients . Histopathological examination of the brain specimens obtained from 18 patients who died 0 to 32 days after the onset of the COVID-19 symptoms of COVID-19 showed only hypoxic changes and did not show encephalitis or other specific brain changes referable to the virus. There was no cytoplasmic viral staining in immunohistochemical analysis. The virus was detected at low levels in six brain sections obtained from five patients .

One should keep in mind though that the diagnosis of coronavirus particles by electron microscopy is challenging due to the numerous similarly appearing normal cellular structures (e.g., clathrin-coated vesicles, which are normal cell organelles involved in intracellular transport or cross-sections of the rough endoplasmic reticulum), creating significant controversy (see e.g., (Miller & Brealey, 2020; Su, Gao, et al., 2020; and Varga et al., 2020a Varga et al., , 2020b ). In fact, it was pointed out that "there are inherent difficulties in discrimination of cellular vesicles from viral particles solely by morphological evidence" (Su, Gao, et al., 2020) . In other words, the electron microscopic evidence alone is not sufficient for unambiguous identification of virions, with many erroneously identified particles being found in incorrect cellular location, or lacking diagnostic features of coronavirus. We provided an in-depth discussion of this issue in our recent review (Elrashdy et al., 2020) .

It was also hypothesized that CNS infection with involvement and dysfunction of the cardiorespiratory brainstem centers may contribute to the death of infected animals or patients (Li, Bai, et al., 2020; Xia & Lazartigues, 2008) . hACE2 transgenic mice that inoculated intracranially or intranasally with virus particles commonly exhibited a disseminated infection of the DVC (area postrema, nucleus tractus solitarius, and dorsal motor nucleus of the vagus) (Netland et al., 2008) . This complex contains efferent and afferent projections of the vagus nerve to the lungs and respiratory tracts, suggesting that the vagus nerve may also serve as a neuronal route for viral entry into the brain. This leads to the hypothesis that the dysfunction of the cardiorespiratory brainstem center may be at least partially responsible for the death of CoV-infected animals or patients (Li, Bai, et al., 2020; Xia & Lazartigues, 2008) . A cytokine storm with excessive levels of pro-inflammatory cytokines (IL-6, GM-CSF, IL-2, interferon-γ, IL-7, inducible protein 10, TNF-α, macrophage inflammatory protein 1-α, monocyte chemoattractant protein 1, and monocyte chemoattractant protein 1) may also contribute to the lethality of the COVID-19 infection (Desforges et al., 2019; Mehta et al., 2020) . This is illustrated by recent reports of a COVID-19 patient with an acute necrotizing encephalopathy, a rare complication observed in infections with viruses such as influenza, and related to a cytokine storm in the brain without direct viral invasion (Poyiadji et al., 2020; Vonck et al., 2020) .

A postmortem histological analysis of the brain of a 71-yearold man who died from complications of COVID-19 revealed the presence of several types of pathological lesions, such as a widespread hemorrhagic and lesion of white matter with clusters of macrophages, necrotic blood vessels, and perivascular inflammation, acute axonal injury, demyelination, marked lesions of central axonal injury, associated extravasated blood, and surrounding myelin loss (Reichard et al., 2020) . Despite all of these dramatic neurological manifestation in this patient, a routine histological examination of the olfactory bulb/nerve revealed only aging-related corpora amylacea (Reichard et al., 2020) . More globally, the presence of brain tissue edema and partial neuronal degeneration were reported in autopsy reports of deceased COVID-19 patients (Xu, Shi, et al., 2020) .

It appears that all the major requirements for efficient hijacking of the nervous cells/tissues by the SARS-CoV-2, which caused the COVID-19 outbreak, are in the place. This includes utilization of the ACE2 (which is present on the surfaces of the cells in a wide variety of human tissues, including the brain) as a cellular entry receptor and the presence of the spike glycoprotein possessing affinity for ACE2, which is ~10-to 20-fold higher than that of the SARS-CoV spike protein (Walls et al., 2020; Wrapp et al., 2020) . All this indicates that SARS-CoV-2 may have higher neuroinvasive potential compared to previous HCoVs. It was also shown that the SARS-CoV-2 receptor ACE2 is expressed in ECs of cerebral capillaries, and within the brain parenchyma in both neurons and microglia (Yamagata et al., 2020) .

However, there is no complete expression profile of the catalytic enzymes that are required for CoV entry, such as transmembrane serine protease 2 (TMPRSS2) and Furin, on the surface of the nervous tissue cells, from where the COVID-19 can inter to the human nervous system. | 7

and TMPRSS2, as well as Furin) that mediate infection by SARS-CoV-2 . This was further complemented by the analysis of the single-cell RNA-Seq data from whole mouse olfactory bulb from juvenile mice (age postnatal day 26-29; Zeisel et al., 2018) as well as single-cell RNA-Seq data from the olfactory bulb from the adult male mice (8 to 12 weeks old) . These analyses revealed that two key genes involved in SARS-CoV-2 entry, namely ACE2 and TMPRSS2, were expressed in the samples from the whole olfactory mucosa in mouse and human in addition to the thiol proteases cathepsins Ctsb and Ctsl . However, neither olfactory sensory neurons nor olfactory bulb neurons expressed these genes (with the exception of cathepsins Ctsl), which instead were expressed in several stem, perivascular, and support cells . Such results suggest that anosmia and related disturbances in odor perception in COVID-19 patients could be associated with the SARS-CoV-2 infection of nonneuronal cell types .

Vavougios proposed that the furin-like cleavage site of the CoV spike protein could be an important determinant for the neurotropism of this virus (i.e., its ability to infect nerve tissue) (Vavougios, 2020a (Vavougios, , 2020b . In fact, it was found that cleavage of the S-protein by furin or furin-like proteases is important for the invasion and virulence of SARS-CoV and MERS-CoV (Millet & Whittaker, 2015) . Furthermore, the proteases determine the host tissue tropism and specificity of these CoVs (Millet & Whittaker, 2015) , letting them infect the nervous system via membrane fusion. However, additional studies are necessary to determine if the furin-like cleavage site on the spike protein of SARS-CoV-2 plays a certain role in its invasion of the nervous system. Another important issue that also requires careful future analysis is the presence and sustainability of the nervous system damage after the cure of the COVID-19 infection. This became especially troublesome in light of the fact that the anosmia and ageusia, which are frequently observed among COVID-19 patients, also serve as characteristic and prodromal nonmotor manifestations of Parkinson's disease (Haehner et al., 2011; Oppo et al., 2020) .

It is also possible that other SARS-CoV-2 receptors may exist, or another cellular entry mode is utilized by SARS-CoV-2 for hijacking the nervous cells/tissues. These possibilities were supported by Radzikowska et al. (2020) , whose analysis suggested the presence of a different receptor repertoire potentially involved in the SARS-

such as the co-expression of ACE2, CD147 (BSG), and CD26 (DPP4).

Changes in the expression of these receptors related to gender, age, smoking, and obesity, as well as to the status of the disease may further contribute to COVID-19 severity and morbidity patterns (Radzikowska et al., 2020) . Using a combination of structural and molecular modeling approaches, Fantini et al. (2020) revealed that the sialic acids linked to host cell surface glycoproteins and ganglioside can also serve as an additional cellular entry route for SRSR-CoV-2 (Fantini et al., 2020) , similar to influenza virus, SARS-CoV, and

HCoV OC43 (Lu et al., 2008; Tortorici et al., 2019) . A new type of ganglioside-binding domain (111-158) at the tip of the N-terminal domain of the SARS-CoV-2 S protein was identified, which is fully conserved among clinical isolates worldwide, and sialic acid and ganglioside bind chloroquine with high affinity (Fantini et al., 2020) .

Although there is a 77% sequence identity between SARS-CoV and SARS-CoV-2, Hassanzadeh et al. (2020) discovered that the SARS-CoV-2 S protein has a slightly higher positive charge than SARS-CoV. This is because it has five less negatively charged residues and four more positively charged residues, which may be why the protein has a higher affinity for negatively charged regions of other molecules in both specific and nonspecific interactions (Hassanzadeh et al., 2020) . Analysis of the peculiarities of the S protein binding to the host ACE2 receptor showed a 30% higher binding energy for SARS-CoV-2 than the SARS-CoV S protein (Hassanzadeh et al., 2020) . Therefore, SARS-CoV-2 is expected to have higher efficiency than SARS-CoV in reaching the brain after entering through the cells (Hassanzadeh et al., 2020) .

Cigarette smoke has been shown to increase patient susceptibility to COVID-19, with smokers suffering from the disease being far more likely to develop critical illnesses (Guo, 2020; Patanavanich & Glantz, 2020; Zhao, Meng, et al., 2020) . One study of 1,099 COVID-19 patients revealed that only 4.7% of nonsmokers required mechanical ventilation, were admitted to an intensive care unit, or died, compared to 12.3% of smokers . Although the exact mechanism for such an association is uncertain, one of the potential explanations can be found in the fact that cigarette smoke can increase the levels of ACE2 expression in the lungs of mammals . In the case of SARS-CoV infection, ACE2 levels may influence the progression of the disease: within a group of mice engineered to express human ACE2, mice with the highest levels of ACE2 mRNA displaying the shortest survival time after being exposed to SARS-CoV (McCray et al., 2007) .

In agreement with this model, analysis of the data sets of large, small, and bronchial airway epithelium of current and former smokers revealed a noticeable upregulation of pulmonary ACE2 gene expression in all data sets of smokers compared to nonsmokers, irrespective of tissue subset . Another study also showed that ACE2 expression in the lower airways is upregulated by active cigarette smoking and COPD, which might help explain the higher risk of serious COVID-19 in patients that smoke . Interestingly, in this study, smoking status was significantly related to the levels of the ACE2 gene expression in the airways of these participants, where current smokers showed a significantly higher gene expression than never-smokers, whereas former smokers' levels were between current and never-smokers . This ACE2 overexpression in human bronchial epithelial cells is mediated by nicotine exposure specifically through the α7 subtype of nicotine acetylcholine receptors (α7-nAChR) (Russo et al., 2020) , which was significantly correlated with the expression of CHRNA7 gene encoding the α7-nAChR. The levels of the CHRNA7 expression were also correlated with the body mass index, raising an intriguing scenario, where the nicotine receptor mediation of ACE2 may also be related to the high proportion of obese individuals among the COVID-19 cases .

Further support is given by the fact that cigarette smoke might cause a dose-dependent upregulation of ACE2, in both rodent and human lungs .

There are also reports indicating that smoking may result in higher levels of androgen hormones like testosterone. The androgen receptor has been shown to increase the expression of TMPRSS2 (Qing et al., 2020) , and sex steroid modulation of TMPRSS2 serves as a possible mechanism that may explain the differences in SARS-

CoV-2 infection rates between females and males (Stopsack et al., 2020) . In line with these observations, RNA-sequencing data analysis for lung and oral epithelial tissues of human COVID-19 patients clearly demonstrated that both TMPRSS2 and ACE2

were significantly upregulated among smokers versus nonsmokers (Chakladar et al., 2020) . It was also found that there was a correlation between the smoking-mediated upregulation of the androgen pathway and the upregulation of ACE2/TMPRSS2 expression, and that the androgen receptor gene and ADAM17 (a key mediator of ACE2 activity) were upregulated in smokers (Chakladar et al., 2020) .

Furthermore, smoking was shown to induce furin upregulation, although to a lesser degree than ACE2 .

Taken together, these observations support the idea that epithelial cells may be more susceptible to the COVID-19 virus as a result of smoking (Chakladar et al., 2020) . But what one can say about smoking and neurotropism of CoVs? ACE2 expression in human brain vessels was significantly elevated by cigarette smoke extract (CSE) treatment. Furthermore, it was found that ACE2 expression is increased in vessels exposed to diabetes or smoking and in ischemic brains, which leads to them being more susceptible to infection.

Also, ACE2 expression was upregulated in primary cultured human blood vessels with diabetes when compared to healthy vessels . Therefore, the regulation of ACE2 expression by cigarette smoke in the brain likely has a significant effect on SARS-CoV-2 susceptibility, and might facilitate viral dissemination . The harmful effects of CSE on the BBB can upregulate several genes related to inflammation, such as VCAM1 and ICAM1, which also have destructive effects on the BBB .

CoVs are primarily not neurotropic viruses, and their primary target is the respiratory epithelium. However, although the ACE2, which serves as a major receptor for SARS-CoV and SARS-CoV-2, and which is an enzyme attached to the cell membranes of cells in the arteries, lungs, kidney, heart, and intestines, it can also be found in glial cells in spinal and brain neurons (Palasca et al., 2018) . SARS-CoV and SARS-CoV-2 can therefore use these receptors to enter, attach, multiply, and damage the neuronal tissue. Studies on mice also show that SARS-CoV can enter the brain through the cribriform bone or through a retrograde transfer via the olfactory epithelium, and in 7 days can reach the brain. The virus can also enter the brain directly due to a disruption of the BBB during the viremia phase of the disease. The invasion of peripheral nerve terminals by CoV is another postulated mechanism, after which the virus enters the CNS through the synapse connected route. Given that SARS-CoV-2 is very similar to SARS-CoV, it is likely that it can invade the CNS using the same methods as SARS-CoV.

However, though the receptor's expression pattern can determine which cells can be infected, not all cells that express the receptor, or even cells with the highest receptor expression, are necessarily the primary targets of the viral attack. This can be exemplified by the mouse hepatitis virus (MHV) studies, where the MHVR receptor is highly expressed in the liver, but barely so in neurons.

In contrast, the MHV strain JHM.SD, which is highly neurovirulent,

is not able to replicate in the liver during viral infection, (Bender et al., 2010) . Mapping the viral tropism in vivo and the virulence factors that contributed to pathogenesis required considerable time and energy. Surprisingly, it was revealed that tissue tropism was not solely impacted by the viral spike protein, but instead by other viral "background genes," such as replicase and nucleocapsid, in addition to different viral accessory genes, in which can also be used for the determination of tropism (reviewed in (Weiss & Leibowitz, 2011) ).

Pathogenesis can therefore not be directly inferred from the knowledge of the receptor and spike protein alone. Future studies on SARS-CoV-2 will define tissue tropism and whether it parallels SARS-CoV or not (Weiss, 2020) .

Let us look more closely on the potential routes for SARS-CoV-2 entry into the CNS (see Figure 2 ) REVIEW COVID-19 might cause respiratory failure and death not through damage to the lungs, but by affecting the brain.

Baig et al. have suggested (Baig et al., 2020) that the SARS-CoV-2 may access the brain using the same "transcribrial route" defined for other pathogens that target the CNS (such as Naegleria fowleri causing meningoencephalitis) (Baig, 2016) and for the delivery of drugs and embryonic stem cells to brain (Baig, 2017) . It is also likely that the SARS-CoV-2 dissemination across the cribri- (Elrashdy et al., 2020) ). From her the viral and/or its components can spread from renal anastomosis into CNS via nerve supply. Although the cross talk between human organs in health and diseases is a very complicated processes go through huge number of mechanisms, but it well documented in a dramatically pattern (Armutcu, 2019; Lu et al., 2015) patients affected by SARS-CoV (Netland et al., 2008) . As per Baig et al., by virtue of its presence in general circulation, SARS-CoV-2 can be passed into cerebral circulation, where it will have a chance to interact with ACE2 expressed in the capillary endothelium, and thereby to infect cells there, causing damage to the endothelial lining and providing viral access to the brain (Baig et al., 2020) .

Importantly, SARS-CoV-2 interaction with the ACE2 receptors expressed in neurons can lead to virus entry and begin a cycle of viral budding and neuronal damage without substantial inflammation, as was reported previously in SARS-CoV cases (Netland et al., 2008) . It should be noted that well before the anticipated neuronal damage occurs, the endothelial ruptures in cerebral capillaries, together with bleeding within the cerebral tissue, can be fatal in COVID-19 patients (Baig et al., 2020) . SARS-CoV-2's movement to the brain via the cribriform plate located near the olfactory bulb can act as an additional path that would allow the virus to reach and affect the brain. All this clearly indicates that the observation of hyposmia or an altered sense of smell in an early and uncomplicated stage of a COVID-19 patient should be thoroughly investigated for CNS involvement (Baig et al., 2020) .

There is a growing interest in the study of the OE. It is the most proximal axonal area of the human brain, with neurons that can be regenerated. Many studies show a strong link between olfactory deficiency (e.g., loss of smell) and neurodegenerative diseases such as (Alzheimer's and Parkinson's diseases, AD and PD, respectively). The main neurological manifestation of COVID-19 is the loss of taste or smell. Since most instances of smell loss occur without significant rhinorrhea or nasal congestion, the virus likely targets the chemical senses in ways that are different from those utilized by other common cold-causing agents or endemic coronaviruses (Cooper et al., 2020) . Therefore, it seems that the olfactory route represents a logical pathway of SARS-CoV-2 entry into the CNS. In fact, analysis of SARS-CoV-2 prevalence in clinical specimens showed that the viral copy number found in nasal swabs is ~200-fold higher than those found in the bronchoalveolar lavage or pharyngeal swabs Zou et al., 2020) . The utilization of the olfactory route is further supported by the fact that issues with smell have been reported internationally, reporting a prevalence as high as 85% in a large, multicenter European survey (Lechien et al., 2020) . Furthermore, high-intensity ACE2 staining was detected in olfactory mucosal biopsies, with a 200to 700-fold ACE2 enrichment in the olfactory neuroepithelium (sustentacular cells) relative to the nasal respiratory or tracheal epithelial cells . This cellular tropism of SARS-CoV-2 may underlie its high transmissibility and association with dysfunction of olfactory neuroepithelium receptors in the nasal and oral mucosa, and also suggests the existence of a viral reservoir that may be a good candidate for intranasal therapy. In contrast, ACE2 was not found in immature and mature olfactory neurons . Taken together, these observations of the enhanced expression of ACE2 localized to the olfactory neuroepithelium of the human airway suggests that COVID-19 infection and replication may take place in the apical layer of nasal and olfactory mucosa, resulting in olfactory loss and acting as a possible entry point of the virus into the CNS, causing neurological symptoms Mao et al., 2020) . Furthermore, although the postmortem examination showed no inflammatory infiltrates or neuronal necrosis in the brains of the deceased COVID-19 patients analyzed histologically, and although the SARS-CoV-2 RNA copy numbers were predominantly low in the brain, the corresponding values detected in the olfactory bulb were higher than those in the brainstem, supporting the hypothesis of the viral entry into the brain via the lamina cribrosa (Menter et al., 2020) . In light of the facts that the swabs from olfactory sustentacular cells bear ~200-fold SARS-CoV-2 RNA copy numbers compared to those found in the bronchoal- 

Humans have evolved highly sophisticated barrier systems to prevent the entry of potentially harmful substances into the nervous system. The CNS contains four types of such barriers, which are the BBB, the choroid plexus (CP, which is a vascular tissue found in all cerebral ventricles that produces the CSF of the CNS) blood-cerebrospinal fluid barrier (BCSFB), the meningeal-brain barrier (which consists of the three membranes that envelop the brain and spinal cord, with the meninges in mammals being the dura mater, the arachnoid mater, and the pia mater), and the lymphatic vessel-brain barrier. In addition, there is one more barrier of the PNS, namely, the blood-nerve barrier (BNB). However, some viruses are able to directly manipulate the BBB or BCSFB to enter the CNS, whereas others hijack host immune cells or travel within peripheral nerves. The BNSB may represent the main route of the SARS-CoV-2 for breaching the nervous system (CNS and PNS).

The nervous system has barriers that isolate it from the bloodstream and help it achieve the complex microenvironment control necessary for complex neural signaling. Although all these main physiological nervous barriers differ in location, size, morphology, and function, their main structural units are the epithelial or ECs, which are known to express both ACE2 and TMPRSS2. The vascular | 11

ECs constitute the interface between the interstitial fluid of the CNS tissue and the blood. The blood-cerebrospinal fluid barrier (BCSFB) comprises a single layer of endothelial/epithelial cells at the CP or meninges. It is a fluid-brain barrier consisting of two membranes that separate blood from CSF at the capillary level, and CSF from brain tissue. Epithelial cells separate the plexus or meningeal blood from the CSF. The BCSFB regulates most of the exchange of ions, water, and other substances that can be found between blood and CSF. A few localized brain regions, such as the pineal and the area postrema, are called circumventricular organs (CVOs) and lack the vascular BBB, but rather have a barrier of ependymal cells between the CSF and CVO tissue, and of tanycytes between adjacent brain tissue and the CVO. Therefore, the BCSFB represents a regulatory interface comprising a monolayer of cells that separates the blood from the fluids of the CNS (Abdul Razzak et al., 2019; Doran et al., 2013) .

As most neurological disorders in COVID-19 patients are demonstrated in somewhat aged patients, the well-documented effects of age on the endothelial/epithelial barriers and specifically of the BNSB should be kept in mind. The exponential decline in integrity/ permeability of these barriers is linked to age as reviewed in detail by Delaney and Cambell (2017) . It is becoming increasingly evident that the pericytes are susceptible to age-dependent deterioration at the BBB. Breakdown of the paracellular pathway, pericyte loss, and transcellular permeability can exacerbate the events linked with age, and can lead to the extravasation of blood-borne material. The susceptibility of endothelium toward many intrinsic destructive agents is known to increase with aging (Delaney & Campbell, 2017) . Again, these facts may provide some explanations of why the SARS-CoV-2 particles were detected in all postmortem nervous tissue biopsy examined (see Table 1 ).

The BBB, located in the brain microvessels, is the largest brain barrier in terms of length, (close to 650 km) and surface (10-20 m 2 ). It protects the brain from exogenous and circulating threats and maintains . It is therefore possible that SARS-CoV-2 can use these mechanisms of neuroinvasion, and may also primarily enter the CNS by crossing the BBB. Interactions between SARS-CoV-2 and components of the BBB therefore have the potential to significantly impact neuropathogenesis. Further support to the BBB route hypothesis is given by the facts that BBB is disrupted in hypertension (Setiadi et al., 2018) and hypertension is a frequent comorbidity for COVID-19 (Espinosa et al., 2020; Gold et al., 2020; Parveen et al., 2020; Surma et al., 2020; Zaki et al., 2020) .

The BBB is a highly restrictive barrier that protects the CNS from aberrant immune responses and pathogens in the periphery.

BBB is formed by the brain ECs lining the cerebral microvasculature with about 50-100 times tighter contacts than that in the peripheral microvessels and astrocytes, which are in direct contact with the ECs (Abbott, 2002) . Astrocytes play a central role in maintaining homeostasis within the CNS by regulating the integrity of the BBB, as well as by controlling the uptake of excess neurotransmitters and other extracellular factors that may perturb neurotransmission (Abbott, 2002) . It was also pointed out that several biomolecules, such as Endothelin-1 (ET-1), Glutamate, IL-1β, IL-2, IL-6, TNFα, macrophage inflammatory proteins MIP-2, and nitric oxide might modulate the BBB permeability, with at least some of these biomolecules being released by astrocytic glial cells (Abbott, 2002) .

Notably, a deregulated immune response serves as an important mediator of COVID-19 mortality (Pedersen & Ho, 2020) , as critical illnesses are more likely to develop in patients with heightened levels of inflammatory cytokines Qin et al., 2020; Tan et al., 2020; Yang, Shen, et al., 2020) . These conditions are referred to as ''cytokine storms'' and result in an increase in vascular permeability, which facilitates immune cell efflux into affected tissues, while also possibly worsening pneumonia . Importantly, most of the proteins that were shown to modulate the BBB permeability (Abbott, 2002) (Hackenberg et al., 2020) and to the increase in BBB permeability. Such BBB permeability elevation represents a link between MMPs (specifically MMP-9) and CNS disorder (Bongetta et al., 2020; .

Under physiologic conditions, the BBB is relatively impermeable, though recently the list of biomolecules capable of modulating the permeability, integrity, and tightness of the BBB was extended by inclusion of the SARS-CoV-2 spike protein (Buzhdygan et al., 2020) .

It was shown here that introduction of the viral spike proteins into the model systems recapitulating the essential features of the BBB resulted in a breach of the barrier. Furthermore, SARS-CoV-2 spike protein was shown to increase the MMP3, CCL5, CXCL10, ICAM-1, and VCAM-1 (which are cell adhesion molecules, CAMs) gene expression levels, alter mRNA levels of interleukins IL-1β and IL-6, and trigger a pro-inflammatory response on brain ECs that may further contribute to an altered state of BBB function (Buzhdygan et al., 2020) . These observations were used to support a hypothesis that SARS-CoV-2 is potentially a neuroinvasive virus since it can turn on the machinery to enable the migration of infected immune cells into the brain parenchyma (Buzhdygan et al., 2020) . In blood vessels, the increase in VCAM1 and ICAM1 in response to the pro-inflammatory cytokines plays a crucial role in the adhesion of leukocytes, including macrophages and neutrophils, with the end result being disruption of the BBB and inflammation of the brain . Viral gene products can also contribute to the BBB breakdown through upregulation of many biomarkers (Swanson & McGavern, 2015) . In the first report, PCR detected the SARS-CoV-2 in the CSF of a 40-year-old Los Angeles resident with type 2 diabetes mellitus and obesity, who developed fever and temporary loss of consciousness (syncope) and was admitted for encephalitis (Duong et al., 2020; . In the second report, the SARS-CoV-2 genome was detected and sequenced in a 42-year-old resident of São Paulo with suspected demyelinating disease (Domingues et al., 2020) For example, analysis of the MERS-CoV tissue pantropism (i.e., the ability of a virus to indiscriminately affect many kinds of tissues) has shown that MERS-CoV can enter the bloodstream after endothelial infection in vivo (Hocke et al., 2013) . This hypothesis is further supported by the presence of SARS-CoV-2 in the CSF fluid of a COVID-19 patient presenting viral encephalitis (Vonck et al., 2020; .

The mammalian BNB is the second most restrictive vascular system after the BBB (Ubogu, 2020) . Peripheral nerves are structurally divided into three compartments: epineurium, where fenestrated macrovessels directly derived from the extrinsic peripheral nerve blood supply are located; the inner perineurium, which surround the innermost endoneurium compartment of the peripheral nerve. The BNB, formed by the tight junction-forming microvessels within peripheral nerve endoneurium, allows for effective axonal signal transduction.

The restricted permeability of this barrier protects the endoneurial microenvironment from drastic concentration changes in the vascular and other extracellular spaces. This barrier supplies cover to the nerves everywhere in human body, constitutes the ECs, and is characterized by very compact structure (Figure 2d1,d2) . The analysis of its transcriptome provided insights into the mechanisms of microbial entry from the bloodstream into peripheral nerves, human BNB response to injury, and response to viral infections.

Inflammatory and metabolic diseases, as well as traumatic lesions of the nervous system, are accompanied by BNB/BDB (blood dorsal ganglion barrier) opening. Opening of the BNB (or permeable/ leaky BNB) can be the first sign preceding neuropathic pain, which synchronizes with many agents, such as cytokines, growth factors, and microRNAs (Reinhold & Rittner, 2020 (Li et al., 2012 (Li et al., , 2013 Matsuda et al., 2004) . Although there are no data concerning SARS-CoV-2 trafficking across the BNB, some observations concerning the barrier permeability may point to the ability of SARS-CoV-2, or at least its proteins, to target the BNB and to modulate its peripheral nerve immunosurveillance in COVID-19 pathogenesis.

In fact, several disorders, such as Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy, acute inflammatory demyelinating polyradiculoneuropathy, and vasculitic neuropathy are characterized by hematogeneous leukocyte infiltration (predominantly monocytes and T cells) into peripheral nerves via the BNB, with resultant demyelination and axonal degeneration (Ahmad & Rathore, 2020; Chen, Wu, et al., 2020; Conde Cardona et al., 2020; Lai et al., 2020; Mao et al., 2020; Vonck et al., 2020; Zubair et al., 2020) . Therefore, it seems that leukocyte extravasation alone can impact junctional protein expression in the BNB.

The chemokine-mediated and/or hyperproduction of interleukin-6 signaling has been implicated in the autoimmune neuropathies pathogenesis (Cardona & Ubogu, 2013; van Doorn et al., 2008; Ubogu, 2013) . Clinically, GBS is characterized by limb or cranial nerve weakness, loss of deep tendon reflexes, sensory, and dysautonomic symptoms due to peripheral nerves and root demyelination, and/or axonal damage. About 60% of all GBS are preceded by respiratory or GI complications, with a presentation latency varying from 3 days to 6 weeks (van Doorn et al., 2008) , which corresponds with COVID-19 GBS patients (Agosti et al., 2020) . The suggested infection-mediated immune response that results in higher circulation of pro-inflammatory cytokines (Agosti et al., 2020; Ahmad & Rathore, 2020; van Doorn et al., 2008) reaches the peripheral nerve through the BNB.

Finally, the GBS and other peripheral nerve symptoms reveal that the PNS can be hijacked by SARS-CoV-2 through direct attack of microvessel ECs, or indirect attack via immune-mediated response. As ACE2 is widely expressed on the epithelial cells of the oral mucosa, SARS-CoV-2 can breach the BNB accessing the CNS via the cranial nerve using axonal transport machinery . The upregulated vascular endothelial growth factor VEGF (C and A) is associated with COVID-19 endothelial barrier dysfunction (Ackermann et al., 2020; Yin et al., 2020) , and specifically with the BNB (Lim et al., 2014) . As VEGF is also related to angiopoietins (Ang I and Ang II), accumulation of Ang II facilitates the elevation of VEGF and inversely augments Ang II, which forms a vicious cycle in the release of inflammatory cytokines including TNF-α, IL-1β, IL-6, IL-8, and ICAM-1, which causes BBB and BNSB disruption .

The CP of the BCSFB displays fundamentally different properties in comparison to the BBB. With a brisk blood flow (10 times higher than that of the brain) and highly permeable capillaries, the human CP provides the CNS with a high turnover rate of fluid (~400 ml/ day) that contains peptides, micronutrients, and hormones for neu- As discussed under the BBB route, the SARS-CoV-2 particle could not be isolated and/or detected in the CSF, although the RT-PCR was positive and two fragments from ORF1a of the 1,580-nucleotide were obtained (Domingues et al., 2020; Moriguchi et al., 2020) , the CSF of those patients showed an albuminocytologic dissociation with increased protein level (98 mg/dl, reference value: 8-43 mg/ dl) and normal cell count (2 × 10 6 /L, reference value: 0-8 × 10 6 /L) (Agosti et al., 2020; Dalakas, 2020; Ellul et al., 2020) . Eleven COVID- appears that a post-viral-triggered immune response similar to other post-viral-induced GBS cases or other post-viral autoimmune neurologic disorders occurred (Dalakas, 2020) . As SARS-CoV-2 spike protein interacts with ganglioside dimers and the GalNAc residue of GM1 for anchoring to cell surface gangliosides, cross-reactivity between epitopes within the SARS-CoV-2 spike-bearing gangliosides and signature sugar residues of surface peripheral nerve glycolipids is very likely. Similar molecular mimicry has been shown between peripheral nerve glycolipids and Campylobacter jejuni or Zika virus (Dalakas, 2020) . This raised many questions, such as how does this SARS-CoV-2 genomic material reach the CSF? Is it through the BCSFB? Is it accompanied by the delivery of the translated SARS-CoV-2 proteins? Are the increased CSF protein concentration and cell counts in COVID-19 linked with BCSFB and BNB permeability as immune-mediated responses?

A third way SARS-CoV-2 can enter the CNS could be via the spreading of the virus in the lymphatic drainage system of the brain (Bostanciklioglu, 2020) . Although the glymphatic vessel structure mainly contains endothelial lining cell systems, this pathway is rather contradictory at the moment, and other researchers do not confirm lymphatic draining entry (Li, Guan, et al., 2020) . The lymphatic/glymphatic brain system (which is a glial-dependent waste clearance pathway in the brain that serves as a "front end" for the waste clearance connected downstream to an authentic lymphatic network) was discovered rather recently (Benveniste et al., 2019) . It has a vascular histological structure, which is quite similar to that of the endovascular blood system (Aspelund et al., 2015; Da Mesquita et al., 2018) . Importantly, endothelial lining cells of this system express both the ACE2 and TPMRSS2 genes, where the SARS-CoV-2 can access it. In line with these features, electron microscopy analysis revealed the presence of viral inclusion structures in ECs (Varga et al., 2020b) . The lymphatic/glymphatic system is different from traditional blood circulation since it is an open, afferent (one-way) system. The major function of this system is to collect the soluble waste proteins and metabolic products from the CNS and drain them away. This unidirectionality raises an important and logical question, namely, how can it bring the viral particles to the CNS tissue, being a one-way drainage system? In addition, the lymphatic drainage function is impaired in age-dependent manner (Da Mesquita et al., 2018) .

Therefore, the aforementioned BBB route is more favorable for CNS infection by SARS-CoV-2, especially in patients with severe COVID-19 complicated with the cytokine storm, which increases the BBB permeability, thereby facilitating the immune cell efflux into the affected tissues. At least in the severe cases, the virus (free or in vacuoles) is disseminated into many organs including the vasculature system, and can cause endothelilitis by attacking the endothelium.

This may explain the frequently observed prothrombotic state with in situ clot formation and the impaired microcirculatory function across different organs in COVID-19 patients. Based on these observations, it was suggested that one of the approaches to affect the course of COVID-19 would be to take some steps to stabilize the endothelium during viral replication, specifically in vulnerable patients with preexisting endothelial dysfunctions, which are commonly associated with the male sex, smoking, hypertension, diabetes, obesity, and established cardiovascular disease, all being linked to adverse outcomes in COVID-19 (Varga et al., 2020b) .

Although the direct neuroinvasion via hematogeneous spread or migration of SARS-CoV-2 through the olfactory tract are possible infection routes to the CNS Wu & McGoogan, 2020) , the virus could also gain access from the periphery (Esposito et al., 2020) . It has been postulated that brain stem invasion may occur via the vagal afferents from the upper airways, lung, and GI (Esposito et al., 2020; Li, Bai, et al., 2020) . Furthermore, one cannot exclude the role of GI tract involvement (a notion giving some tribute to the prospective gut-brain connection). In fact, the GI represents an important but mostly underestimated niche for SARS-CoV-2 replication. This is because the GI epithelium has higher relative expression of ACE2 receptor than the lungs. Furthermore, SARS-CoV-2

can directly infect the intestinal cells and efficiently replicate there.

Finally, it was pointed out that the clinical outcome was worse for COVID-19 patients with concomitant GI symptoms who required mechanical ventilation due to increased acute respiratory distress . One study suggests that SARS-CoV-2-related diarrhea and the GI dysfunction are not merely accessory symptoms, but serve as a possible marker of the involvement of the enteric nervous system/enteric glial cell (ENS/EGC) in pathogenesis, and suggests an alternative pathophysiological mechanism underlying SARS-CoV-2 neuroinvasion (Esposito et al., 2020) . Here, the gut might serve as the "entrance door," by which viruses may either directly neuroinvade or indirectly immunologically prime the ENS or ascend to the CNS through intestinal vagal afferents (Esposito et al., 2020) . This hypothesis is supported by the fact that there is a strict interconnection between the ENS and the EGCs and that the gut epithelium is part of a neuroepithelial unit crucial for gut homeostasis (Esposito et al., 2020) .

It was also established that in the case of MERS-CoV infection, the enteric involvement could take place before the respiratory infection (Zhou et al., 2017) . Furthermore, brain infection was observed in mice infected with MERS-CoV either intranasally or by intragastric inoculation (Zhou et al., 2017) . Although finding brain infection in mice with intranasal MERS-CoV injection is not surprising and was actually expected, the fact that mice that underwent intragastric inoculation with MERS-CoV showed infectious virions in both brain and lung homogenates 5 days after the inoculation was | 15 REVIEW rather surprising (Zhou et al., 2017) . The retrograde axonal transport and transsynaptic transfer are well-documented for other types of coronavirus such as the avian bronchitis virus and the swine HEV (Li et al., 2013; Matsuda et al., 2004) .

EGCs express the major histocompatibility complex class II and functionally work as antigen-presenting cells for both innate and adoptive immune cells localized in the gut-associated lymphoid tissue (GALT) . GALT houses many types of immune cells, such as T lymphocytes (γδ T lymphocytes). Upon activation by viral infection, GALT could initiate many immunological responses, such as transition of native CD4 + lymphocytes into different subtypes (T h 1, T h 2, T h 17, T reg , T sup , and CD8 + ). Furthermore, an enormous release of IL-6 and other inflammatory mediators also occurs upon activation, contributing to the acute respiratory distress as observed in the COVID-19-induced cytokine storm (Esposito et al., 2020; Mehta et al., 2020) and to the increase in the endothelium permeability, as aforementioned.

It was shown that the susceptibility to the SARS-CoV-2-inflicted GI damage of the inflammatory bowel disease (IBD) patients is determined by the dysregulated mucosal ACE2 and TMPRSS2 expression in the colon and ileum in IBD (Krzysztof et al., 2020) . This deregulation was further enhanced by advanced age, smoking, and active disease that served as potential additional risk factors defining the vulnerability of IBD patients to COVID-19 through alterations in receptor expression (Krzysztof et al., 2020).

intestinal organoids (hSIOs, which are the 3D structures that are grown from adult stem cells (ASCs) and recapitulate key aspects of the organ from which the ASCs were derived) (Lamers et al., 2020) .

SARS-CoV-2 was demonstrated by confocal-and electron-microscopy, since the clusters of the extracellular viral particles (80-120 nm) were detected in the lumen of organoid and in the apical side of enterocytes associated with double membrane vesicles (Lamers et al., 2020) . Could the viral particles of these disintegrated-infected cells somehow reach and infect the glial intestinal cells, which are known to express ACE2 and TMPRSS2/furin? Could this scenario be repeated in other organs such as the heart, lungs, kidney, and even cutaneous tissues? Similar to SARS-CoV and SARS-CoV-2 infecting the human intestinal epithelial organoid (Lamers et al., 2020) , SARS-CoV-2 was shown to directly infect engineered human blood vessel organoids in vitro (Monteil et al., 2020) . Using both immunochemistry and electron microscopy, SARS-CoV-2 viral particles were found in skin endothelium of patients presenting with chilblains (the painful inflammation of small blood vessels in the skin) (Colmenero et al., 2020) . As SARS-CoV-2 multiplies in the vascular cells of the skin area, can it go through the blood withdrawn by a mosquito bite?

Ultrastructural examination identified typical CoV particles characterized by the spike structure in cytoplasm of hepatocytes in two COVID-19 cases . Also, SARS-CoV-2 particles were found in heart, kidney, and lung autopsy of postmortem samples (Pesaresi et al., 2020) . Therefore, SARS-CoV-2 may first infect blood vessels' ECs prior to infection of local tissues (Monteil et al., 2020) , and then be disseminated into many organs, including the human nervous system (Colmenero et al., 2020; Monteil et al., 2020; Varga et al., 2020b) . (Abassi et al., 2020) and dendritic cells (Yang, Chu, et al., 2020) , but the mature viral particles could not detected intra or extracellular from both of cells type. Furthermore, the electron microscopic postmortem examination of the lung tissues clearly showed that the SARS-CoV particles and SARS-CoV-2 antigens are present and distributed in both alveolar macrophages, as well as in the lymph nodes and the spleen Shieh et al., 2005) .

Previous data from 15 autopsies indicated that the SARS viral particles and genomic sequences were detected in a large number of circulating monocytes, lymphocytes, and lymphoid tissues. They were also found in the mucosa of the intestine, the epithelial cells of the respiratory tract, the neurons of the brain, the epithelium of the renal distal tubules, and macrophages in different organs, suggesting that the virus could infect multiple cell types in different organs (Gu et al., 2005) . One interesting find was that a large proportion of lymphocytes in the circulation and lymphoid organs contained the virus, as observed in the TEM image of a circulating T lymphocyte in a patient who had SARS 6 days after onset of a fever, which may indicate that these circulating lymphocytes carrying viral molecules could reach the CNS and PNS via BBB, BCSFB, or BNB, or through all of these barriers. Based on this interesting result the mechanism of SARS pathogenesis was postulated (Gu et al., 2005) , which appeared to be working until today. It is likely that the viral infection may convert these cells into long living macrophages (Mφ) and promote their migration into extrapulmonary organ/tissues, where they become infected resident cells (viral reservoir) and as inflammatory signals producer, serve as a Trojan horse in other organs (Abassi et al., 2020) , with others cell types such as leukocytes, ECs, smooth muscle cells, pericytes, inflammatory cells, neurones, or glial cells (Jaunmuktane et al., 2020) . A CD68 immunostain revealed that the macrophage infiltrated the cerebral hemispheres and subcortical white matter lesion associated with an axonal injury, and a perivascular acute disseminated encephalomyelitis (ADEM)-like appearance (Jaunmuktane et al., 2020; Reichard et al., 2020) .

Many viruses have been shown to enter the extracellular doublemembrane vesicle (EDMV) or exosome avenues during intrahost spreading and synthesis (Badierah et al., 2020) . As previously reviewed in detail, all positive-sense single-stranded RNA viruses (including SARS-CoV and MERS-CoV) use, redirect, and rearrange host cell membranes as part of the viral genome transcription and replication tactic, harnessing their nonstructural protein apparatus nsp1-16 (Elrashdy et al., 2020) . This tactic allows them to produce doublemembrane vesicles of different size and configuration, carrying different levels of viral particle structures, from dsRNA to full mature viral particles, which would be released as EDMV or exosomes during the release from the host cells, or as a result of the post cell-host rapture. SARS-CoV-2 seems to be using a similar avenue of replication and release. This conclusion is based on the careful postmortem histopathological electron microscopy analysis, and further confirmed using the in vitro SARS-CoV-2 cultured on Vero E6 cells (Ogando et al., 2020) . In fact, electron microscopy revealed that the ultrastructural changes induced by both SARS-CoV and SARS-CoV-2 are very similar and take place at comparable times after infection.

However, the important differences between the two viruses were the facts that, (a) SARS-CoV-2 generated higher levels of intracellular viral RNA, but 50-fold less infectious viral progeny was recovered from the culture medium, (b) upon passaging in Vero E6 cells, SARS-CoV-2 was apparently under strong selection pressure to acquire adaptive mutations in its spike protein gene (Ogando et al., 2020) .

These mutations changed or deleted a putative furin-like cleavage site in the region connecting the S1 and S2 domains of the S-protein and resulted in a very prominent phenotypic change in plaque assays (Ogando et al., 2020) .

Of note, SARS-CoV-2 could infect almost all human body organs and tissues (Ackermann et al., 2020; Colmenero et al., 2020; Elrashdy et al., 2020) . The infected cells are shedding the exosomes (EDMVs). Furthermore, apoptotic or the diffuse damage of infected cells can lead to the release of their contents in a form of different types of EDMVs containing different viral structures (ranging from viral dsRNA to mature viral particles), to infected the adjacent new cells/tissues and expanded to circulate systemically and disseminate to reaching distant tissues (Elrashdy et al., 2020) . This hypothesis is supported by Bulfamante et al., 2020; Colmenero et al., 2020; Paniz-Mondolfi et al., 2020 , where viral particles were detected in ECs of lungs, kidneys, skin chilblains, and CNS of vascular system and organs-cross talk via the vascular system. The TEM analysis of the postmortem frontal lobe brain sections showed the presence of viral particles. Pleomorphic spherical viral-like particles having variation in the size and shape were found either individually or within the small vesicles of ECs. The possible active pathogen transcellular penetration (entry-transit process) across the brain microvascular ECs into the neural niche was evidenced as blebbing of viral-like particles coming in/out of the EC wall. Neural cell bodies exhibited distended cytoplasmic vacuoles containing enveloped viral particle exhibiting electron dense centers with distinct envelope projections ending in round "peplomeric" structures typical of a coronavirus particle (Paniz-Mondolfi et al., 2020) . In the light of these findings, it seems logical that the virus can access the brain directly through the permanent destabilization of the BBB, spe- 

It is known that there are functional connections between the ACE2 expression and nicotine exposur e in lungs and other organ systems, such as the kidneys and heart.

It is likely that because of these functional connections and due to the capability of nicotine to interact with the components of other renin angiotensin system, smoking can promote COVID-19 cellular entry through the nAChR signaling pathway. Notably, nAChRs are found on the surfaces of many of the same cells that express ACE2

in the kidneys, lungs, circulation, and in the brain, and immune cells (Changeux, 2010; Nordman, Muldoon, et al., 2014; Nordman, Phillips, et al., 2014; Tolu et al., 2013) . Therefore, smoking can impact COVID-19 pathophysiology and have a clinical outcome in several organ systems . As ACE2 is expressed in the brain and functionally interacts with nAChRs (Ferrari et al., 2007 (Ferrari et al., , 2008 Oakes et al., 2018) , it was hypothesized that if neural cells, such as epithelial cells, are more vulnerable to infection in smokers since nicotine stimulation of the nAChR can increase ACE2 expression within them . This is an important point since it was shown that mRNA from the closely related SARS-CoV, which also binds ACE2 as a mechanism of cell entry, can be detected in brain and CSF of infected individuals (Chong et al., 2004; Inoue et al., 2007; Zhang et al., 2003) .

Furthermore, SARS-CoV's ability to enter neurons was established in the experimental systems using recombinant human ACE2 as the point of entry (Kaparianos & Argyropoulou, 2011; Netland et al., 2008) .

Considering this scenario, Olds and Kabbani Figure 3 represents three escalating phases of COVID-19 disease progression. Increased vascular permeability is also a hallmark change that occurs in the process of a cytokine storm (Ye

Classification of COVID-19 disease stages. The figure illustrates three escalating phases of COVID-19 disease progression, with hypothesis of blood-endothelial/epithelial barriers integrity/permeability scale associated with age and comorbidities diseases over the three stages. The blood-endothelial barriers are representative for all body barriers and specifically for blood-nervous system barrier (BNSB). Progressive increase in inflammatory cytokine and chemokines eventually leads to cytokine storm in a profile similar to in sepsis cases, which eventually leads to endothelial barrier dysfunction. Many other biomarkers molecules (in addition to the cytokine storm elements) have a direct effect on the BNSB as discussed in text. The times on the x axis are approximate. The figure designed based on and adapted from (Akhmerov & Marban, 2020; Delaney & Campbell, 2017; Doran et al., 2013; Elrashdy et al., 2020; Li, Liu, et al., 2020; Siddiqi & Mehra, 2020) . + to >4+ indicative for barrier integrity/permeability like scale, IIA (stage II without hypoxia) IIB (Stage II with hypoxia). Tumor necrosis factor (TNF-α), interleukin 1β (IL-1β), IL-6, GCSF: granulocyte-colony stimulating factor, interferon gamma-induced protein-10, monocyte chemoattractant protein-1, and MCA-protein 1: macrophage inflammatory proteins 1-α et al., 2020). Although it is known that the cytokine storm (hypercytokinemia) has devastating effects on the respiratory system pro- (Koyuncu et al., 2013) SARS-CoV-2 can use leukocytes as an intermediate host cell before spreading into CNS from circulatory system (Huang, Zheng, et al., 2020) . In fact, such "Trojan horse" mechanism (McGavern & Kang, 2011) , where circulating leukocytes are used by viruses to carry them across the BBB, was described for HIV (Kaul et al., 2001) , Zika virus (Ayala-Nunez et al., 2019) , and HCoV-229E (Collins, 2002; Desforges et al., 2007; Patterson & Macnaughton, 1982) . In other words, SARS-CoV-2 is potentially able to establish a reservoir in leukocytes converting them into the delivery vehicles disseminating infection outside the respiratory tracts and spreading it into the other tissues including CNS (Huang, Zheng, et al., 2020) .

Transmission electronic microscopy analysis of a brain tissue specimen obtained from the SARS patient succumbed to encephalopathy revealed the presence of SARS-CoV-like viral particle, and a SARS-CoV strain was isolated from this sample, clearly demonstrating the neurotropic potential of this virus (Xu et al., 2005) .

Furthermore, cytokine/chemokine assay showed elevated expression of a cytokine, monokine induced by interferon-γ (MIG), and interferon-γ-inducible protein 10 in this sample, and the immunohistochemical analysis revealed that a major source for MIG production in the brain was gliocytes (Xu et al., 2005) . These findings supported the idea that viral entry to CNS might trigger the infiltration of immune cells and the release of cytokines and chemokines, which contribute to the BBB permeability and/or damage.

Therefore, there is clearly an important interplay between the SARS-CoV-2 and the immune system, where dysfunctional immune responses contributes to the disease progression (Tay et al., 2020) . For example, rapid viral replication and secondary cellular injury during the SARS-CoV-2 promoted the increase in the secretion of inflammatory cytokines, such as IL-4, IL-10, IFNγ, IL-1β, and TNF-α, and the cytokine storm is initiated when the levels of released cytokines are injurious to host cells. The presence of a cytokine storm in severe COVID-19 patients is suggested by their high plasma levels of the inflammatory cytokines . The presence of a cytokine storm combined with the elevated d-dimer (which is a fibrin degradation fragment produced when a blood clot gets dissolved in the body, and which, therefore, serves as a reflection of the presence of thrombosis (blood clotting) and/or thrombotic embolism) and ferritins levels were also reported in SARS-CoV-2-infected patients (Mehta et al., 2020; .

Previous studies on sepsis revealed that sepsis-associated cognitive impairment and other neurological symptoms can be triggered by the cytokine storm-induced BBB disruption and resulting neuroinflammation (Nwafor et al., 2019) . This clearly indicates that the activation of the immune system is not only protecting the organism, but also is capable of inducing serious harm, thereby representing a double-edged sword. Contributing factors to the harmful side are the overactivation of the immune system, infection-induced cytokine storm, and the increased immunoglobulin levels in CSF . In line with these mechanisms, neurologic features in severe SARS-CoV-2 infection were shown to be combined with the elevated IgG levels and the presence of the oligoclonal bands (which are defined as at least two CSF electrophoresis bands seen in the CSF samples with no corresponding band present in the serum) in the CSF . Furthermore, the development of acute necrotizing encephalopathy or GBS in virus-infected patients can be associated with intracranial cytokine storms | 19 REVIEW leading to the breakdown of the BBB without direct viral invasion of the CNS (Dalakas, 2020) . In the classic view, acute lung injury and ARDS represent an inflammatory disruption of the epithelial and endothelial cellular barriers of the alveolar-capillary unit, with ensuing microvascular hyperpermeability and flooding of alveolar spaces (Matthay & Zemans, 2011) .

Another illustration of the double-edged sword concept of immune response activation in SARS-CoV-2 infection is given by the complement system, activation of which represents the first response of the host immune system against SARS-CoV-2 infection.

However, "everything is good, which is good in moderation," and uncontrolled complement activation can be harmful as well. In fact, the virus infection of the lungs and other organs can cause complement overactivation leading not only to the acute and chronic inflammation, but to the vasculopathy, for example, EC dysfunction, intravascular coagulation, and thrombus formation, thereby contributing to the multiple organ failure and death (Noris et al., 2020) . In other words, such uncontrolled complement activation might initiate some terminal pathways accounting for what clinicians and pathologists are observing in COVID-19 patients, that is, "although the lungs are ground zero, the virus reach can extend to many organs, including the heart and blood vessels, kidneys, gut, and brain" (Noris et al., 2020; Wadman et al., 2020) . The activation of complement component C3 exacerbates SARS-CoV-associated ARDS (Gralinski et al., 2018) , whereas C3-C5 complement deposits are abundant in the lung biopsies from patients with COVID-19 (Risitano et al., 2020) .

C5a signaling through its G-protein coupled receptor C5aR1/CD88

increased BBB permeability in neuroinflammatory disease settings in vivo (Jacob & Alexander, 2014) . It is highly likely that "inflamm-aging" (which is a chronic progressive increase in the pro-inflammatory status associated with the aging process (Franceschi et al., 2000) ) is correlated with increased risk of a cytokine storm in some critical elderly patients with COVID-19 infection (Meftahi et al., 2020) .

There are numerous pathways that can be utilized by SARS-CoV-2 to breach the body's defenses reach the PNS and CNS. SARS-CoV-2 or its components reach the nervous system through direct contact specifically in severe COVID-19 cases, or indirect contact through multiple mechanisms of immune-mediated responses in mild-tomoderate COVID-19 cases. We are discussing here that there are at least seven candidate routes, which the mature or immature SARS-CoV-2 components could use to reach the CNS and PNS, utilizing the within-body cross talk between organs. Obviously, utilization of any one of these routes is sufficient to make SARS-CoV-2 neurotropic.

The authors, reviewers and editors affirm that in accordance to the policies set by the Journal of Neuroscience Research, this manuscript presents an accurate and transparent account of the study being reported and that all critical details describing the methods and results are present.

The authors declare that there are no conflict of interest. 

The peer review history for this article is available at https://publo ns.com/publo n/10.1002/jnr.24752.

Vladimir N. Uversky https://orcid.org/0000-0002-4037-5857

Elrashdy M. Redwan https://orcid.org/0000-0001-8246-0075

The lung macrophage in SARS-CoV-2 infection: A friend or a foe?

Astrocyte-endothelial interactions and blood-brain barrier permeability

Approaches to cns drug delivery with a focus on transporter-mediated transcytosis

Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19

Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review

Generation of a transgenic mouse model of middle east respiratory syndrome coronavirus infection and disease

Neurological manifestations and complications of Covid-19: A literature review

Covid-19 and the heart

The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture

Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system

Olfactory and gustatory abnormalities in Covid-19 cases

Severe neurologic syndrome associated with middle east respiratory syndrome corona virus (MERS-CoV)

Organ crosstalk: The potent roles of inflammation and fibrotic changes in the course of organ interactions

Central nervous system manifestations of Covid-19: A systematic review

A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules

Zika virus enhances monocyte adhesion and transmigration favoring viral dissemination to neural cells

Dancing with Trojan horses: An interplay between the extracellular vesicles and viruses

Primary amoebic meningoencephalitis: Neurochemotaxis and neurotropic preferences of Naegleria fowleri

Emerging insights for better delivery of chemicals and stem cells to the brain

Evidence of the Covid-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms

A murine virus (jhm) causing disseminated encephalomyelitis with extensive destruction of myelin

Extracellular vesicles and a novel form of communication in the brain

Murine coronavirus receptors are differentially expressed in the central nervous system and play virus strain-dependent roles in neuronal spread

The glymphatic system and waste clearance with brain aging: A review

The blood brain barrier in HIV infection

Coronavirus infection of the central nervous system: Host-virus stand-off

Innate immune responses in the ageing lung

Do matrix metalloproteases mediate the sars-cov-2-related damage to the central nervous system?

Sars-cov2 entry and spread in the lymphatic drainage system of the brain

Effects of a "new" human respiratory virus in volunteers

Nonneuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia

The adaptation of two human coronavirus strains (oc38 and oc43) to growth in cell monolayers

First ultrastructural autoptic findings of SARS-CoV-2 in olfactory pathways and brainstem

Infectability of human brainsphere neurons suggests neurotropism of SARS-CoV-2

The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier

Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2

Chemokines: Methods and protocols

Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection

Smoking-mediated upregulation of the androgen pathway leads to increased sars-cov-2 susceptibility

Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures

Nicotine addiction and nicotinic receptors: Lessons from genetically modified mice

Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology

Neuroinvasion of the highly pathogenic influenza virus h7n1 is caused by disruption of the blood brain barrier in an avian model

A murine virus (jhm) causing disseminated encephalomyelitis with extensive destruction of myelin

Clinical and immunological features of severe and moderate coronavirus disease 2019

Elevated ACE-2 expression in the olfactory neuroepithelium: Implications for anosmia and upper respiratory SARS-CoV-2 entry and replication

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study

Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. medRxiv

Altered Covid-19 receptor ace2 expression in a higher risk group for cerebrovascular disease and ischemic stroke

Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: Challenges in determining a sars diagnosis

Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and sars-cov with implications for clinical manifestations, transmissibility, and laboratory studies of Covid-19: An observational study

Olfactory dysfunction in coronavirus disease 2019 patients: Observational cohort study and systematic review. Open Forum Infectious Diseases

In vitro detection of apoptosis in monocytes/macrophages infected with human coronavirus

SARS-CoV-2 endothelial infection causes COVID-19 chilblains: Histopathological, immunohistochemical and ultrastructural study of seven paediatric cases

Neurotropism of SARS-CoV 2: Mechanisms and manifestations

Covid-19 and the chemical senses: Supporting players take center stage

The meningeal lymphatic system: A new player in neurophysiology

Neuroinvasion and inflammation in viral central nervous system infections

Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease

Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system

The blood brain barrier: Insights from development and ageing

Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system? Viruses

Activation of human monocytes after infection by human coronavirus 229E

West nile virus: Crossing the bloodbrain barrier

First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease

Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system

Concepts and mechanisms: Crossing host barriers. Cold Spring Harbor Perspectives in Medicine

Meningoencephalitis without respiratory failure in a young female patient with Covid-19 infection in downtown Los Angeles

Single-cell analysis of olfactory neurogenesis and differentiation in adult humans

Neurological associations of COVID-19

On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity

Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children

Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: A systematic review and meta-analysis

Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection

Nicotine modulates the renin-angiotensin system of cultured neurons and glial cells from cardiovascular brain areas of wistar kyoto and spontaneously hypertensive rats

Differential regulation of the renin-angiotensin system by nicotine in WKY and SHR glia

A previously undescribed coronavirus associated with respiratory disease in humans

Inflamm-aging. An evolutionary perspective on immunosenescence

Human coronaviruses: Insights into environmental resistance and its influence on the development of new antiseptic strategies

Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients

Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients

Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice

COVID-19 and comorbidities: A systematic review and meta-analysis

Electron microscopy of SARS-CoV-2: A challenging task

Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis

Multiple organ infection and the pathogenesis of SARS

Clinical characteristics of coronavirus disease 2019 in China

Smoking links to the severity of Covid-19: An update of a meta-analysis

Collagen turnover in relation to risk factors and hemodynamics in human intracranial aneurysms

Olfactory loss in Parkinson's disease. Parkinson's Disease

Tissue distribution of ACE2 protein, the functional receptor for sars coronavirus. A first step in understanding sars pathogenesis

A new virus isolated from the human respiratory tract

The characteristics of HDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose-only exposure device

Considerations around the SARS-CoV-2 spike protein with particular attention to Covid-19 brain infection and neurological symptoms

Purification and biophysical properties of human coronavirus 229E

Emerging human Middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs

Coronaviridae: The viruses and their replication

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

Potential of sars-cov-2 to cause CNS infection: Biologic fundamental and clinical experience

Sars-cov-2 detected in cerebrospinal fluid by pcr in a case of Covid-19 encephalitis

Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted

Complement and blood-brain barrier integrity

Microvascular injury and hypoxic damage: Emerging neuropathological signatures in Covid-19

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (Covid-19) with gastrointestinal symptoms

Does Covid-19 infect the brain? If so, smokers might be at a higher risk

Local renin-angiotensin ii systems, angiotensin-converting enzyme and its homologue ACE2: Their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome

Pathways to neuronal injury and apoptosis in HIV-associated dementia

Detection of coronavirus 229E antibody by indirect hemagglutination

Novel coronavirus is putting the whole world on alert

Neurological complications during treatment of Middle East respiratory syndrome

Inflammatory olfactory neuropathy in two patients with Covid-19

Virus infections in the nervous system

Extrarespiratory manifestations of Covid-19

SARS-CoV-2 productively infects human gut enterocytes

The pathogenesis of murine coronavirus infection of the central nervous system

Isolation of rhinoviruses and coronaviruses from 38 colds in adults

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (Covid-19): A multicenter European study

Selective disruption of the blood-brain barrier by zika virus

Heterogeneity of human gammadelta T cells and their role in cancer immunity

Covid-19 and nicotine as a mediator of ace-2

Ace-2 expression in the small airway epithelia of smokers and copd patients: Implications for Covid-19

SARS-CoV-2 and viral sepsis: Observations and hypotheses

Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

The neuroinvasive potential of sars-cov2 may play a role in the respiratory failure of Covid-19 patients

Coronavirus infection of rat dorsal root ganglia: Ultrastructural REVIEW characterization of viral replication, transfer, and the early response of satellite cells

Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication

Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia

Blood-nerve barrier dysfunction contributes to the generation of neuropathic pain and allows targeting of injured nerves for pain relief

Kidney-brain crosstalk in the acute and chronic setting

Lipid rafts are involved in SARS-CoV entry into vero e6 cells

Neurologic manifestations of hospitalized patients with coronavirus disease

Hiv penetration of the bbb

The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice

The acute respiratory distress syndrome: Pathogenesis and treatment

Lethal infection of k18-hACE2 mice infected with severe acute respiratory syndrome coronavirus

Illuminating viral infections in the nervous system

Coronaviruses

Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease

The possible pathophysiology mechanism of cytokine storm in elderly adults with Covid-19 infection: The contribution of "inflame-aging

Covid-19: Consider cytokine storm syndromes and immunosuppression

Postmortem examination of Covid-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction

Visualization of putative coronavirus in kidney

Caution in identifying coronaviruses by electron microscopy

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis

Inhibition of sars-cov-2 infections in engineered human tissues using clinical-grade soluble human ACE2

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

Influenza virus infection aggravates stroke outcome

Increased plasma matrix metalloproteinase-9 levels contribute to intracerebral hemorrhage during thrombolysis after concomitant stroke and influenza infection

Pathways exploited by flaviviruses to counteract the blood-brain barrier and invade the central nervous system

Does sars-cov-2 invade the brain? Translational lessons from animal models

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2

The alpha4 nicotinic receptor promotes CD4+ T-cell proliferation and a helper T-cell immune response

Axon targeting of the alpha 7 nicotinic receptor in developing hippocampal neurons by gprin1 regulates growth

The case of complement activation in Covid-19 multiorgan impact

Age, inflammation, and disease location are REVIEW critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease

Targeting the blood-brain barrier to prevent sepsis-associated cognitive impairment

Nicotine and the renin-angiotensin system

SARS-coronavirus-2 replication in Vero E6 cells: Replication kinetics, rapid adaptation and cytopathology

Is nicotine exposure linked to cardiopulmonary vulnerability to Covid-19 in the general population?

Smelling and tasting" Parkinson's disease: Using senses to improve the knowledge of the disease

Tissues 2.0: An integrative web resource on mammalian tissue expression

Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Association of diabetes and hypertension with disease severity in Covid-19 patients: A systematic literature review and exploratory meta-analysis

Smoking is associated with COVID-19 progression: A meta-analysis

How west nile virus crosses the blood-brain barrier

Replication of human respiratory coronavirus strain 229e in human macrophages

SARS-CoV-2: A storm is raging

Immunopathogenesis of coronavirus infections: Implications for SARS

Coronaviruses: Hepatitis, peritonitis, and central nervous system disease

Effects of microbes on the immune system

SARS-CoV-2 identification in lungs, heart and kidney specimens by transmission and scanning electron microscopy

COVID-19-associated acute hemorrhagic necrotizing encephalopathy: Imaging features

Multiorgan and renal tropism of SARS-CoV-2

Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China

Evaluating MERS-CoV entry pathways

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Neuropathology of Covid-19: A spectrum of vascular and acute disseminated encephalomyelitis (adem)-like pathology

Characteristics of the nerve barrier and the blood dorsal root ganglion barrier in health and disease

Early penetration of the blood-brain-barrier by hiv

Complement as a target in Covid-19?

Covid-19 and smoking: Is nicotine the hidden link?

Targeting and crossing the blood-brain barrier with extracellular vesicles

Mucous cytokine levels in chronic rhinosinusitis-associated olfactory loss

Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic?

The role of the blood-brain barrier in hypertension

Immunohistochemical, in situ hybridization, and ultrastructural localization of sars-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan

Covid-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal

Cigarette smoke exposure and inflammatory signaling increase the expression of the sars-cov-2 receptor ACE2 in the respiratory tract

Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2

Neuropathological features of Covid-19

Viral encephalitis and neurologic diseases: Focus on astrocytes

Viral disruption of the blood-brain barrier

Tmprss2 and Covid-19: Serendipity or opportunity for intervention? Cancer Discovery

The authors reply

Renal histopathological analysis of 26 postmortem findings of patients with Covid-19 in China

Coronavirus sars-cov-2 and arterial hypertension-Facts and myths

Portals of viral entry into the central nervous system

Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza a virus

The trinity of Covid-19: Immunity, inflammation and intervention

Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement

Proinflammatory cytokines in the olfactory mucosa result in Covid-19 induced anosmia

Structural basis for human coronavirus attachment to sialic acid receptors

Chemokine-dependent signaling pathways in the peripheral nervous system

Biology of the human blood-nerve barrier in health and disease

Identification of a new human coronavirus

Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome

Electron microscopy of SARS-CoV-2: A challenging task-Authors' reply

Endothelial cell infection and endotheliitis in Covid-19

The continuum of sars-cov-2's neurotropism and the potential for immune-mediated neuronal injury

Host proteases as determinants of coronaviral neurotropism and virulence

Extracellular vesicles of u937 macrophage cell line infected with DENV-2 induce activation in endothelial cells ea.Hy926

Early evidence of pronounced brain involvement in fatal Covid-19 outcomes

Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2

A rampage through the body

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-Infected pneumonia in

Role of the blood-brain barrier in rabies virus infection and protection

Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis

Detection of SARS-CoV-2 in different types of clinical specimens

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

Forty years with coronaviruses

Coronavirus pathogenesis

Characterization and complete genome sequence of a novel coronavirus, coronavirus hku1, from patients with pneumonia

Cryo-em structure of the 2019-ncov spike in the prefusion conformation

Coronavirus-induced demyelination occurs in the absence of inducible nitric oxide synthase

Nervous system involvement after infection with Covid-19 and other coronaviruses

Characteristics of and important lessons from the coronavirus disease 2019 (Covid-19) outbreak in China: Summary of a report of 72314 cases from the Chinese center for disease control and prevention

Angiotensin-converting enzyme 2 in the brain: Properties and future directions

Detection of severe acute respiratory syndrome coronavirus in the brain: Potential role of the chemokine mig in pathogenesis

Mechanism of thrombocytopenia in Covid-19 patients

Pathological findings of Covid-19 associated with acute respiratory distress syndrome

Downregulation of spinal angiotensin converting enzyme 2 is involved in neuropathic pain associated with type 2 diabetes mellitus in mice

Biological properties of extracellular vesicles and their physiological functions

Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients

Attenuated interferon and pro-inflammatory response in sars-cov-2-infected human dendritic cells is associated with viral antagonism of stat1 phosphorylation

Plasma ip-10 and mcp-3 levels are highly associated with disease severity and predict the progression of Covid-19

The pathogenesis and treatment of the cytokine storm' in Covid-19

Vascular endothelial growth factor (VEGF) as a vital target for brain inflammation during the Covid-19 outbreak

Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with Covid-19 disease severity and fatality: A systematic review

Molecular architecture of the mouse nervous system

Cytokine release syndrome in severe Covid-19: Interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization

Guillain-Barre syndrome associated with sars-cov-2 infection: Causality or coincidence?

The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis

Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis

Human intestinal tract serves as an alternative infection route for middle east respiratory syndrome coronavirus

SARS-CoV-2: Underestimated damage to nervous system

Understanding the neurotropic characteristics of SARS-CoV-2: From neurological manifestations of COVID-19 to potential neurotropic mechanisms

A novel human coronavirus oc43 genotype detected in mainland China

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review

Coronaviruses-drug discovery and therapeutic options